TickerFactsScreenerDevelopers

Adaptimmune Therapeutics PLC (ADAPY) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2014: $1.37M2015: $5.08M2016: $11.51M2017: $24.64M2018: $3.91M2019: $1.59M2020: $2.34M2021: $8.57M2022: $29.50M2023: $4.68M2024: $886.0K$886.0K
2014Capital Expenditures (USD)2024
Fiscal YearCapital ExpendituresChange YoY
2024$886.0K-81.1%
2023$4.68M-84.1%
2022$29.50M+244.0%
2021$8.57M+266.3%
2020$2.34M+47.0%
2019$1.59M-59.3%
2018$3.91M-84.1%
2017$24.64M+114.2%
2016$11.51M+126.5%
2015$5.08M+271.9%
2014$1.37M—